Impact of Covid-19 Aerosol Box On Intubation Success Rate
NCT ID: NCT06042829
Last Updated: 2023-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2020-11-23
2021-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to compare intubation success rate between intubation with and without aerosol box in real patients, which will determine the chances of efficient intubation and reflect the safety features of the aerosol box.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Taiwan "Aerosol Box" Versus UMMC "Intubation Box"
NCT04385576
Effect of Using Barrier Devices for Intubation in COVID-19 Patients
NCT04412226
Comparing the Efficacy Between Lignocaine Given Via MADgic Atomizer and Lignocaine Pump Spray
NCT06213116
Clinical Evaluation of an Aerosol Protective Intubation Device on Videolaryngoscopic Intubation Difficulty
NCT04865081
Comparison of Bed up Head Elevated Intubation Position With Glidescope Assisted Tracheal Intubation
NCT03357679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Objectives
1. To determine whether intubation with aerosol box will require more time for successful intubation as compared to intubation without the box.
2. To compare the ease of intubation and determine whether intubation using aerosol box will require additional airway manipulation as compared to intubation without using the box.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intubation with aerosol box
Aerosol box group where patient will be intubated using aerosol box
Intubation using aerosol box
Intubation time and ease of intubation using aerosol box
Intubation without Aerosol box
Without aerosol box group whereby patients will be intubated without aerosol box.
Intubation without aerosol box
Intubation time and ease of intubation without aerosol box
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intubation using aerosol box
Intubation time and ease of intubation using aerosol box
Intubation without aerosol box
Intubation time and ease of intubation without aerosol box
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. American Society of Anesthesiologist (ASA) I or II patients
3. Tested negative for COVID-19 prior to surgery
4. Patient scheduled for elective surgery under general anaesthesia
Exclusion Criteria
2. Difficult airway features
3. Body mass index (BMI) of more than 35 kg/m2
4. Body habitus not physically fit into the aerosol box.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Kebangsaan Malaysia Medical Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nurul Najwa Mohd Noor Dr
Role: PRINCIPAL_INVESTIGATOR
National University of Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universiti Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HTM-2020-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.